Indefinite Delivery Contract 36E79724D0023

The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals and medical products, to provide Carbamazepine 200MG tablets. The base year ordering period is June 23, 2024 to June 22, 2025, with four one-year option periods. This contract, valued at up to $4,045,768.94, allows the VA, Department of Defense, Bureau of Prisons, and Indian Health Service to order the tablets, which will be distributed through the VA's and DOD's respective Pharmaceutical Prime Vendor Programs. The original solicitation, issued without a set-aside, sought an uninterrupted source of supply for the Carbamazepine 200MG tablets in package sizes of 100 or 1,000 tablets per bottle. The estimated annual requirements are 7,553 bottles of the 100 tablet size and 9,921 bottles of the 1,000 tablet size. While the contract will mandate use of the generic Carbamazepine product, providers can still prescribe the branded Tegretol product if deemed clinically necessary.

This Indefinite Delivery Contract supports the VA, DOD, Bureau of Prisons, and Indian Health Service in acquiring a key pharmaceutical product, Carbamazepine 200MG tablets, through a reliable supplier. The award to Golden State Medical Supply, a proven manufacturer and distributor, ensures the government customers have an uninterrupted source of this essential medication, which is commonly used to treat conditions such as epilepsy and neuropathic pain. The flexibility of the Indefinite Delivery vehicle allows the agencies to order quantities as needed over the multi-year term of the contract.